.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The U.S. Department of Veterans Affairs (Strategic Acquisition Center Fredericksburg) issued Combined Synopsis/Solicitation 36C10G25Q0112 requesting the NX EQ remOVE DC Impulse Generator under PSC 6515/NAICS 334510. The solicitation is a total small business set-aside and seeks delivery of the specified medical device with nationwide performance. An amendment (0003) extended the due date to December 30, 2025; offers are due by 2025-12-30 23:59 ET.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
No files attached to this RFP.
Many agencies add documentation later or require FOIA requests. Starbridge can automatically retrieve these files for you.
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The U.S. Department of Veterans Affairs issued a combined synopsis/solicitation seeking quotes for an NX EQ remOVE DC Impulse Generator, set aside for small businesses. The solicitation includes multiple attachments (specifications, clauses, price schedule, reporting tool) and was amended to extend the due date. Proposals are to be submitted by the stated deadline and the procurement will be awarded on best value to the government.
Posted Date
Dec 30, 2025
Due Date
Jan 10, 2026
Release: Dec 30, 2025
Close: Jan 10, 2026
The U.S. Department of Veterans Affairs issued a combined synopsis/solicitation seeking quotes for an NX EQ remOVE DC Impulse Generator, set aside for small businesses. The solicitation includes multiple attachments (specifications, clauses, price schedule, reporting tool) and was amended to extend the due date. Proposals are to be submitted by the stated deadline and the procurement will be awarded on best value to the government.
AvailableThe U.S. Department of Veterans Affairs (Veterans Affairs) issued a combined synopsis/solicitation (36C10G26Q0024) seeking NX EQ Capsule Endoscopy systems. An amendment extends the solicitation due date to January 9, 2026 at 11:59 AM ET and states all other terms remain unchanged. The solicitation will be awarded on a best-value basis, is open to eligible businesses, and lists Hosea Berkley as the contracting point of contact.
Posted Date
Dec 29, 2025
Due Date
Jan 9, 2026
Release: Dec 29, 2025
Close: Jan 9, 2026
The U.S. Department of Veterans Affairs (Veterans Affairs) issued a combined synopsis/solicitation (36C10G26Q0024) seeking NX EQ Capsule Endoscopy systems. An amendment extends the solicitation due date to January 9, 2026 at 11:59 AM ET and states all other terms remain unchanged. The solicitation will be awarded on a best-value basis, is open to eligible businesses, and lists Hosea Berkley as the contracting point of contact.
Neuromuscular Blockade Monitoring refers to the process of measuring and assessing the degree of muscle relaxation induced by neuromuscular blocking agents (NMBAs), which are drugs used to induce temporary paralysis, typically during surgical procedures or in intensive care settings. These agents inhibit the transmission of nerve impulses at the neuromuscular junction, leading to muscle relaxation. Monitoring is critical to ensure the appropriate depth of muscle relaxation is achieved and maintained, which helps in optimizing patient safety and the effectiveness of the procedure. Effective neuromuscular blockade monitoring helps in adjusting the dosage of NMBAs, avoiding both underdosing (which may lead to inadequate muscle relaxation) and overdosing (which can result in prolonged paralysis and complications), and ensuring timely and appropriate recovery of muscle function post-procedure.
Posted Date
Dec 18, 2025
Due Date
Jan 7, 2026
This is a Sources Sought notice issued by the U.S. Department of Veterans Affairs for market research purposes. The notice, titled "6515--578-26-2-969-0082 Prep and Pack Workstations (VA-26-00033788)", was published on December 30, 2025. Responses are due by January 15, 2026, at 10:00 AM CST, and it is not a solicitation or obligation by the Government.
Posted Date
Dec 30, 2025
Due Date
Jan 15, 2026
Release: Dec 30, 2025
Close: Jan 15, 2026
This is a Sources Sought notice issued by the U.S. Department of Veterans Affairs for market research purposes. The notice, titled "6515--578-26-2-969-0082 Prep and Pack Workstations (VA-26-00033788)", was published on December 30, 2025. Responses are due by January 15, 2026, at 10:00 AM CST, and it is not a solicitation or obligation by the Government.
Surface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Close: Jan 7, 2026
Neuromuscular Blockade Monitoring refers to the process of measuring and assessing the degree of muscle relaxation induced by neuromuscular blocking agents (NMBAs), which are drugs used to induce temporary paralysis, typically during surgical procedures or in intensive care settings. These agents inhibit the transmission of nerve impulses at the neuromuscular junction, leading to muscle relaxation. Monitoring is critical to ensure the appropriate depth of muscle relaxation is achieved and maintained, which helps in optimizing patient safety and the effectiveness of the procedure. Effective neuromuscular blockade monitoring helps in adjusting the dosage of NMBAs, avoiding both underdosing (which may lead to inadequate muscle relaxation) and overdosing (which can result in prolonged paralysis and complications), and ensuring timely and appropriate recovery of muscle function post-procedure.
Available